No Duplicate KRAS Mutation is Identified on the Same Allele in Gastric or Colorectal Cancer Cells with Multiple KRAS Mutations

Abstract

Codon 12 and 13 mutations in 170 colorectal cancer (CRC) and 66 gastric cancer (GC) specimens were analysed by an ‘enriched’ polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) method. All identified mutations were verified by direct sequencing of the second PCR products. Among the 170 CRC specimens, mutations were identified in 47 (28%) and 13 (7.6%) cases in codons 12 and 13, respectively. In the 66 GC specimens examined, however, mutations in codons 12 and 13 were only detected in two (3.0%) and one (1.5%) cases, respectively. Mutations in both codon 12 and 13 were found in 3/170 (1.8%) CRCs and 1/66 (1.5%) GCs. Duplicate mutations were never identified in the same allele, which was confirmed by direct sequencing of the second amplified products. The majority of colorectal and gastric cancer cells with KRAS mutations are homogeneous because they have the same KRAS mutation. A few colorectal or gastric cancers, however, showed heterogeneity, as verified by the fact that single mutations were identified in the same allele.

Keywords

Colorectal cancer Gastric cancer Molecular heterogeneity

References

Peyssonnaux

Eychene

: The Raf/MEK/ERK pathway: New concepts of activation. Biol Cell 2001; 93: 53–62.

Barbacid

: ras genes. Annu Rev Biochem 1987; 56: 779–827.

Kikuchi

Demo

: ralGDS family members interact with the effecter loop of ras p21. Mol Cell Biol 1994; 14: 7483–7491.

Rodriguez-Viciana

Warne

Dhand

: Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994; 370: 527–532.

Shields

Pruitt

McFall

: Understanding Ras: it ain't over ‘til it's over’. Trends Cell Biol 2000; 10: 147–154.

Vojtek

Cooper

: Rho family members: Activators of MAP kinase cascades. Cell 1995; 82: 527–529.

Almoguera

Shibata

Forrester

: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549–554.

Rodenhuis

van de Wetering

Mooi

: Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 1987; 317: 929–935.

Bos

Fearon

Hamilton

: Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293–297.

10.

Forrester

Almoguera

Han

: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298–303.

11.

Vogelstein

Fearon

Hamilton

: Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525–532.

12.

Lee

Suh

: Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer 1995; 75: 2794–2801.

13.

Fearon

: Molecular genetic studies of the adenoma-carcinoma sequence. Adv Intern Med 1994; 39: 123–147.

14.

Fearon

Vogelstein

: A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–767.

15.

Nagata

Abe

Kobayashi

: Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. Cancer Res 1990; 50: 480–482.

16.

Shaw

Tardy

Benito

: Occurrence of Ki-ras and p53 mutations in primary colorectal tumors. Oncogene 1991; 6: 2121–2128.

17.

Gonzalez-Cadavid

Zhou

Battifora

: Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas. Oncogene 1989; 4: 1137–1140.

18.

Korn

Moerkerk

de Goeij

: K-ras point mutations in routinely processed tissues: nonradioactive screening by single strand conformational polymorphism analysis. J Clin Pathol 1993; 46: 621–623.

19.

Kumar

Dunn

: Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. Oncogene Res 1989; 4: 235–241.

20.

Tada

Yokosuka

Omata

: Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990; 66: 930–935.

21.

Takeda

Ichii

Nakamura

: Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum Mutat 1993; 2: 112–117.

22.

Kahn

Jiang

Culbertson

: Rapid and sensitive nonradioactive detection of mutant K-ras genes via ‘enriched’ PCR amplification. Oncogene 1991; 6: 1079–1083.

23.

Nagasaka

Sasamoto

Notohara

: Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes show different patterns of DNA methylation. J Clin Oncol 2004; 22: 4584–4594.

24.

Dexter

Leith

: Tumor heterogeneity and drug resistance. J Clin Oncol 1986; 4: 244–257.